New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine
No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.
Canadian Task Force recommendation on screening for postpartum depression misses the mark
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new recommendation by the Canadian Task Force on Preventative Health Care which advises against systematic questionnaires for PPD screening with Ob.Gyn News on January 20, 2023.
Menopause Increases Risk of Relapse in Women with Schizophrenia
Menopause is a period of increased risk for women with schizophrenia spectrum disorders, and women are at higher risk for relapse than their age-matched male counterparts.
Weekly Roundup for FEBRUARY 17, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Emergency Resources for Individuals with Perinatal Mental Health Issues
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
Prenatal Lithium Exposure: Neuroimaging Yields Reassuring Results
Functional MRI revealed no differences in brain structure of white matter integrity in lithium-exposed versus non-lithium-exposed children born to mothers with bipolar spectrum disorder.